Correlation Between Shuttle Pharmaceuticals and Orexo AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shuttle Pharmaceuticals and Orexo AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shuttle Pharmaceuticals and Orexo AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shuttle Pharmaceuticals and Orexo AB ADR, you can compare the effects of market volatilities on Shuttle Pharmaceuticals and Orexo AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shuttle Pharmaceuticals with a short position of Orexo AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shuttle Pharmaceuticals and Orexo AB.

Diversification Opportunities for Shuttle Pharmaceuticals and Orexo AB

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Shuttle and Orexo is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Shuttle Pharmaceuticals and Orexo AB ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orexo AB ADR and Shuttle Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shuttle Pharmaceuticals are associated (or correlated) with Orexo AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orexo AB ADR has no effect on the direction of Shuttle Pharmaceuticals i.e., Shuttle Pharmaceuticals and Orexo AB go up and down completely randomly.

Pair Corralation between Shuttle Pharmaceuticals and Orexo AB

Given the investment horizon of 90 days Shuttle Pharmaceuticals is expected to under-perform the Orexo AB. But the stock apears to be less risky and, when comparing its historical volatility, Shuttle Pharmaceuticals is 1.1 times less risky than Orexo AB. The stock trades about -0.74 of its potential returns per unit of risk. The Orexo AB ADR is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  111.00  in Orexo AB ADR on August 31, 2024 and sell it today you would earn a total of  8.00  from holding Orexo AB ADR or generate 7.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Shuttle Pharmaceuticals  vs.  Orexo AB ADR

 Performance 
       Timeline  
Shuttle Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shuttle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Orexo AB ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orexo AB ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Shuttle Pharmaceuticals and Orexo AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shuttle Pharmaceuticals and Orexo AB

The main advantage of trading using opposite Shuttle Pharmaceuticals and Orexo AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shuttle Pharmaceuticals position performs unexpectedly, Orexo AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orexo AB will offset losses from the drop in Orexo AB's long position.
The idea behind Shuttle Pharmaceuticals and Orexo AB ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Commodity Directory
Find actively traded commodities issued by global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities